Therapeutic area

Eye disorders – page 23

369 clinical trials
123 recruiting
134 conditions
27 countries

Clinical trials in Eye disorders

369 trials across Europe, recruiting first

Click a country to filter the trials

Quick filters

369 clinical trials

Arteriosclerosis+2

Not recruiting

InvestigationalNo placebo

Long-term Safety Study of INZ-701 for Patients with ENPP1 and ABCC6 Deficiencies, Including Pseudoxanthoma Elasticum and Generalized Arterial Calcification of Infancy

InvestigationalNo placebo

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Recombinant Human Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Fused To The Fc Fragment Of Igg1
Sponsor:Inozyme Pharma Inc.

Contact Research Centre

Choroid melanoma

Not recruiting

Registered drugNo placebo

Preventing Neovascular Glaucoma in Patients with Large Choroidal Melanoma Using Aflibercept During Proton Therapy

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Aflibercept
Sponsor:Centre Hospitalier Universitaire De Nice

Contact Research Centre

Choroidal dystrophy+1

Not recruiting

InvestigationalNo placebo

Long-term Safety and Efficacy Study of Gene Therapy for Choroideremia and X-Linked Retinitis Pigmentosa Using AAV2-REP1 and AAV8-RPGR in Previously Treated Patients

InvestigationalNo placebo

France

Participants:18–64 years
Substances:Timrepigene Emparvovec
Sponsor:Biogen Idec Research Limited

Contact Research Centre

Corneal dystrophy

Not recruiting

Investigational

Study on the Effectiveness and Safety of STN1010904 Eye Drops for Patients with Fuchs Endothelial Corneal Dystrophy

Investigational

France

Participants:18–64 years · 65+ years
Substances:Sirolimus
Sponsor:Santen Inc.

Contact Research Centre

Retinopathy of prematurity

Not recruiting

Registered drugNo placebo

Long-Term Study on Aflibercept for Retinopathy of Prematurity in Children

Registered drugNo placebo

Bulgaria

Participants:0–17 years
Substances:Aflibercept
Sponsor:Regeneron Pharmaceuticals Inc.

Contact Research Centre

Sjogren's syndrome

Not recruiting

Registered drug

Study on the Effectiveness of Human Normal Immunoglobulin for Treating Painful Nerve Damage in Patients with Primary Sjögren's Syndrome

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Human Normal Immunoglobulin
Sponsor:Les Hopitaux Universitaires De Strasbourg

Contact Research Centre

Optic ischaemic neuropathy

Not recruiting

Registered drugNo placebo

Study on the Effects of Bosentan for Patients with Early Stage Non-Arteritic Anterior Ischemic Optic Neuropathy

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Bosentan
Sponsor:Centre Hospitalier Universitaire Grenoble Alpes

Contact Research Centre

Myopia

Not recruiting

Investigational

Study on the Effects of Atropine Sulfate Monohydrate Eye Drops in Slowing Myopia Progression in Children

Investigational

Czechia

Participants:0–17 years
Substances:Atropine Sulfate Monohydrate
Sponsor:Fakultni Nemocnice Brno

Contact Research Centre

Sjogren's syndrome

Not recruiting

Registered drug

Study on Anifrolumab for Patients with Primary Sjogren's Syndrome

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Anifrolumab
Sponsor:Universitair Medisch Centrum Groningen

Contact Research Centre

Optic glioma

Not recruiting

Investigational

Study on the Safety and Effectiveness of Nerve Growth Factor CHF6467 for Children and Young Adults with Optic Pathway Glioma

Investigational

Italy

Participants:0–17 years · 18–64 years
Substances:Nerve Growth Factor, Recombinant (R100E)
Sponsor:Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Contact Research Centre

Exudative retinopathy

Not recruiting

Registered drugNo placebo

Study on Bevacizumab Injections for Patients with Coats' Disease

Registered drugNo placebo

France

Participants:0–17 years
Substances:Bevacizumab
Sponsor:Fondation A De Rothschild

Contact Research Centre

Retinal vein occlusion

Not recruiting

Registered drugNo placebo

Study on the Effect of Aflibercept Injections in Patients with Central Retinal Vein Occlusion (CRVO) and Spontaneous Retinal Arterial Pulsations (SRAPs)

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Aflibercept
Sponsor:Fondation A De Rothschild

Contact Research Centre

Substances studied in this area

The therapies tested most often in Eye disorders trials.

Aflibercept27 clinical trials Sodium Chloride16 clinical trials Prednisone14 clinical trials Ranibizumab14 clinical trials Dexamethasone11 clinical trials Dexamethasone Phosphate10 clinical trials Fluorescein Sodium10 clinical trials Prednisolone10 clinical trials Nivolumab8 clinical trials

Eye disorders – page 23

Conditions in this area

Clinical trials in Eye disorders

369 clinical trials

Arteriosclerosis+2

Long-term Safety Study of INZ-701 for Patients with ENPP1 and ABCC6 Deficiencies, Including Pseudoxanthoma Elasticum and Generalized Arterial Calcification of Infancy

Choroid melanoma

Preventing Neovascular Glaucoma in Patients with Large Choroidal Melanoma Using Aflibercept During Proton Therapy

Choroidal dystrophy+1

Long-term Safety and Efficacy Study of Gene Therapy for Choroideremia and X-Linked Retinitis Pigmentosa Using AAV2-REP1 and AAV8-RPGR in Previously Treated Patients

Corneal dystrophy

Study on the Effectiveness and Safety of STN1010904 Eye Drops for Patients with Fuchs Endothelial Corneal Dystrophy

Retinopathy of prematurity

Long-Term Study on Aflibercept for Retinopathy of Prematurity in Children

Sjogren's syndrome

Study on the Effectiveness of Human Normal Immunoglobulin for Treating Painful Nerve Damage in Patients with Primary Sjögren's Syndrome

Optic ischaemic neuropathy

Study on the Effects of Bosentan for Patients with Early Stage Non-Arteritic Anterior Ischemic Optic Neuropathy

Myopia

Study on the Effects of Atropine Sulfate Monohydrate Eye Drops in Slowing Myopia Progression in Children

Sjogren's syndrome

Study on Anifrolumab for Patients with Primary Sjogren's Syndrome

Optic glioma

Study on the Safety and Effectiveness of Nerve Growth Factor CHF6467 for Children and Young Adults with Optic Pathway Glioma

Exudative retinopathy

Study on Bevacizumab Injections for Patients with Coats' Disease

Retinal vein occlusion

Study on the Effect of Aflibercept Injections in Patients with Central Retinal Vein Occlusion (CRVO) and Spontaneous Retinal Arterial Pulsations (SRAPs)

Filter the trials

Substances studied in this area

Prefer not to search? Our Concierge searches the trials for you.